Analysts have high hopes for the depression drug, which would be the first in it class if it were to be approved.

Transcranial magnetic stimulation and ketamine have been effective in treating depression. But when patients still struggle ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 17, 2025 12:40 PM EDT ...

Eye movement desensitization and reprocessing (EMDR), an empirically validated tool for treating PTSD, is now being used for performance enhancement in sports and other domains.

Erectile dysfunction doesn’t happen overnight; it develops gradually, often starting with small, subtle changes that many men ...

Otsuka receive CRL from US FDA for sNDA of Rexulti in combination with sertraline to treat adults with post-traumatic stress disorder: Japan Monday, September 22, 2025, 10:00 Hrs ...

Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along ...

Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...

A new study published in Nature Medicine provides more evidence that ketamine’s rapid antidepressant effects may be partially ...

New research published in Nature Neuroscience provides evidence that a non-hallucinogenic analog of psychedelic drugs can stimulate brain cell growth through the same molecular pathway as traditional ...

Detailed price information for Enveric Biosciences Inc (ENVB-Q) from The Globe and Mail including charting and trades.

At pivotal times, medical providers could have helped Alex. Instead, they labeled him an "addict" and chastised him for "bad ...